Broadwood Partners Highlights Growing Opposition to STAAR Surgical's Proposed Sale to Alcon
Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood's Concerns over Deeply Deficient Sale Process, Timing, and Price Shareholders Representing More than 34% of STAAR's Outstanding Common Shares Have
(Financial Post, 2025-10-20T12:45:41Z)